The Core Center for Gene Therapy at the University of Washington School of Medicine (UWSM) will focus on three main areas of research: 1) development of adeno-associated virus and retrovirus vectors for human applications in cystic fibrosis, 2) development of retroviral vectors for gene replacement in primary immunodeficiency syndromes, as well as lysomal storage disorders, 3) retroviral and adenoviral vectors for human application in blood clotting factor deficiencies. A total of 23 investigators who receive over $10 million in independent external support (NIH and CFF) will -regularly use the core facilities and collaborate in development of gene therapy protocols. This work will be supported by an Administrative Component and five other core facilities: Human Applications Core, Vector Development Core, Immunohistochemistry Core, Hematopoiesis Cell Transduction Core, and Animal Core. In addition, the pilot and feasibility program will consist of 5 projects which are related to CF gene therapy and 3 projects which are directed towards gene therapy in other genetic disorders. The 5 CF-related projects include the following: 1) Safety and biologic effect of AAV2/CFTR intranasal and intrabronchial administration in individuals with CF-Preclinical studies, 2) Blockade of Tumor Necrosis Factor and Interleukin-1 to enhance gene therapy in CF, 3) Adeno- associated virus for efficient gene transfer and expression in rabbit airway epithelial cells, 4) Identification of key virulence determinants of P. aeruginosa expressed in vivo and their role in lung infection in CF, 5) CF gene transfer: biliary epithelial cell pathobiology in cystic fibrosis. The 3 non CF-related projects include 1) Transduction of CD 18 gene using retroviral vectors into peripheral blood and bone marrow from children with LAD, 2) Retrovirus-mediated transfer of the human glucocerebrosidase gene into canine long-term hematopoietic stem cells, Retroviral and adenoviral mediated transfer of Factor VIII cDNA transfer into rodent hepatocytes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK047754-04
Application #
2016797
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Mckeon, Catherine T
Project Start
1994-01-15
Project End
1998-12-31
Budget Start
1997-01-01
Budget End
1997-12-31
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Washington
Department
Pathology
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Murnane, R; Zhang, X B; Hukkanen, R R et al. (2011) Myelodysplasia in 2 pig-tailed macaques (Macaca nemestrina) associated with retroviral vector-mediated insertional mutagenesis and overexpression of HOXB4. Vet Pathol 48:999-1001
Metzger, Michael J; McConnell-Smith, Audrey; Stoddard, Barry L et al. (2011) Single-strand nicks induce homologous recombination with less toxicity than double-strand breaks using an AAV vector template. Nucleic Acids Res 39:926-35
Miller, A D; Metzger, M J (2011) APOBEC3-mediated hypermutation of retroviral vectors produced from some retrovirus packaging cell lines. Gene Ther 18:528-30
Halbert, C L; Metzger, M J; Lam, S-L et al. (2011) Capsid-expressing DNA in AAV vectors and its elimination by use of an oversize capsid gene for vector production. Gene Ther 18:411-7
Kiem, Hans-Peter; Ironside, Christina; Beard, Brian C et al. (2010) A retroviral vector common integration site between leupaxin and zinc finger protein 91 (ZFP91) observed in baboon hematopoietic repopulating cells. Exp Hematol 38:819-22, 822.e1-3
Trobridge, Grant D; Wu, Robert A; Hansen, Michael et al. (2010) Cocal-pseudotyped lentiviral vectors resist inactivation by human serum and efficiently transduce primate hematopoietic repopulating cells. Mol Ther 18:725-33
Becker, P S; Taylor, J A; Trobridge, G D et al. (2010) Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vector. Gene Ther 17:1244-52
Doty, Raymond T; Sabo, Kathleen M; Chen, Jing et al. (2010) An all-feline retroviral packaging system for transduction of human cells. Hum Gene Ther 21:1019-27
Enssle, Joerg; Trobridge, Grant D; Keyser, Kirsten A et al. (2010) Stable marking and transgene expression without progression to monoclonality in canine long-term hematopoietic repopulating cells transduced with lentiviral vectors. Hum Gene Ther 21:397-403
Halbert, Christine L; Madtes, David K; Vaughan, Andrew E et al. (2010) Expression of human alpha1-antitrypsin in mice and dogs following AAV6 vector-mediated gene transfer to the lungs. Mol Ther 18:1165-72

Showing the most recent 10 out of 176 publications